The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

Serum IL-6 Levels and 9 CV and Mortality Outcomes

An analysis of the association between blood IL-6 measures from 14 multiethnic, prospective cohorts with follow-up data on any of 9 prespecified outcomes.

Early Antivirals May Cut Child Flu Hospitalization Risk

Antiviral treatment started within 48 hours of symptom onset is linked to a reduced risk for hospitalization among pediatric patients with influenza.

Forced Birth Control in Greenland Violated Women's Rights but Didn't Constitute Genocide, Experts Find

A campaign of forced contraception in Greenland that ran primarily in the 1960s and 1970s violated women's human rights but did not meet the legal definition of genocide,...

AstraZeneca-Amgen Asthma Drug Succeeds in Late-stage Oesophagus Disease Trial

AstraZeneca said on Thursday its asthma drug Tezspire met the main goals of a late-stage trial in patients with a chronic inflammatory disorder ⁠of the oesophagus, offering...

Does PIH Coexist With Skin Inflammation? Experts Weigh In

‘Visible hyperpigmentation may mask persistent erythema and should not be assumed to indicate resolved inflammation,’ according to the authors of a recently published commentary.

Success After a Century Of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough

Stephane Bancel, CEO of Moderna, was at a Lebanese restaurant celebrating a friend’s birthday late on August 13 when he got the call.

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Latest News

An analysis of the association between blood IL-6 measures from 14 multiethnic, prospective cohorts with follow-up data on any of 9 prespecified outcomes.

Antiviral treatment started within 48 hours of symptom onset is linked to a reduced risk for hospitalization among pediatric patients with influenza.

A campaign of forced contraception in Greenland that ran primarily in the 1960s and 1970s violated women's human rights but did not meet the legal definition of genocide,...

AstraZeneca said on Thursday its asthma drug Tezspire met the main goals of a late-stage trial in patients with a chronic inflammatory disorder ⁠of the oesophagus, offering...

‘Visible hyperpigmentation may mask persistent erythema and should not be assumed to indicate resolved inflammation,’ according to the authors of a recently published commentary.

Stephane Bancel, CEO of Moderna, was at a Lebanese restaurant celebrating a friend’s birthday late on August 13 when he got the call.

News All Time

Healthy Diet May Aid Lung Health in Asthma and COPD

A healthier diet is linked to better lung function among adults with asthma or COPD, with the largest gains seen among those with COPD.

Optical Biomarkers Predict Atopic Dermatitis Severity

Composite optical imaging biomarker models accurately assess atopic dermatitis severity and identify clinically normal skin with hidden inflammation, a study finds.

Immune-Mediated Thrombotic Thrombocytopenic Purpura in Man

A man presents with thrombocytopenia and microangiopathic hemolytic anemia, with testing confirming immune-mediated thrombotic thrombocytopenic purpura.

Aussie Flu Season Implications for North America

Data from down under suggest possible relief ahead for the US, but experts emphasize unpredictability.

Venom Immunotherapy Safe in Pediatric Hymenoptera Allergy

Children with Hymenoptera venom allergy experience predominantly mild, local reactions during venom immunotherapy, with no severe systemic reactions in those completing long-term treatment.

Hungary Foreign Ministry Files Report on $964 Million Pandemic-era Ventilator Deals

Hungary's Foreign Ministry has filed a report with prosecutors on suspected fraud ⁠and other crimes involving the 2020 purchase of ventilators during the COVID-19 pandemic...

Frailty Predicts More Than Age: Strategies for Hospitalists

‘Age, by itself, tells us remarkably little about a person’s physiologic reserve, resilience, or ability to recover from acute illness.’

Noninvasive Ventilation Tied to Fewer MAiD Requests in ALS

Patients with amyotrophic lateral sclerosis using noninvasive ventilation were less likely to request medical assistance in dying, a study reports.

Study Doesn't Back Wholesale Switch to Single-Use Endoscopes

Single-use GI endoscopes show technical performance and diagnostic accuracy comparable to, or slightly worse than, reusable ones — findings that don't warrant a wholesale switch to the former.

Diaphragmatic Thickness Linked to Weaning Failure in Infants

Dynamic measures of diaphragmatic thickness during spontaneous breathing may reveal more about an infant's readiness to come off the ventilator.

What to Know About US Measles Cases on the Rise

Two Pennsylvania residents have died due to measles, health officials said on Tuesday, the first U.S. deaths from the disease reported in 2026 and the first in the state in...

FDA Approves Continuous Glucose + Ketone Monitor Device

The Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System was authorized for people ages 2 years and older with diabetes.

First-Line Biologics May Aid Remission in Still Disease

First-line biologic therapy is associated with higher rates of sustained event-free remission than nonbiologic immune modulators in adult-onset Still disease.

Racial Disparities Tied to Resolution of Food Allergy

Race and parental health literacy affect the likelihood of outgrowing food allergies in children, with historically marginalized groups showing the lowest odds of resolution.

‘Getting Them From All Over’: Microplastics and Rheumatology

A growing body of evidence suggests that microplastics not only accumulate in the body but may have damaging effects, including for people with rheumatic diseases.

Anifrolumab vs Belimumab in Lowering SLE Cardiovascular Risk

Anifrolumab treatment is associated with a lower risk for cardiovascular disease than belimumab treatment in patients with systemic lupus erythematosus.

Recommended News For You

Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.

In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.

Novel Psychedelic Promising on Resistant Depression

Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL

Junk Food & Prostate Cancer; 'Office' Star's Stage IV Diagnosis; New Cancer Cluster?

Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?

New imaging guidelines for head and neck cancers, a step toward practice change

Recommended Articles For You

How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care? 

Hypogammaglobulinemia: A Comprehensive Guide for Patients and Caregivers 

Paving the Path to Precision: A Review of TAR-200 in the Evolving Bladder Cancer Landscape 

Neonatal Hematopoietic Transition and Blood Cell Maturation 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Independent Risk Factors for "Deaths of Despair" Found.

2.

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

3.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

4.

Infection Burden High With Myeloma T-Cell Therapies

5.

PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC

1.

Genomic Control of Erythropoietic Stem Cell Renewal

2.

Case-Based Learning on Unexpected Cytopenia Patterns Following Advanced Therapies

3.

Subchorionic Hematoma: Causes, Symptoms, and Treatment 

4.

Clonal Hematopoiesis as a Mechanism of Age-Related Disease

5.

Transformative Insights in Oncology in Daily Practice

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Innovations in Hematology

2.

Case-Based Learning: Oncology

3.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion

4.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion

5.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot